HOME >> BIOLOGY >> NEWS
Depression in African-American men may be barrier to high blood pressure control

A study from The Johns Hopkins University School of Nursing concludes depression may sabotage efforts to control high blood pressure in urban, African-American men. The researchers found no direct link between depression and high blood pressure, but the depressed men were five times more likely to abuse alcohol, leading to behaviors that counteract efforts to control blood pressure.

The study results, published in the July issue of Annals of Behavioral Medicine, found that more than one-fourth of 190 hypertensive black men from inner-city Baltimore were at high risk for depression. The level of depression correlated significantly with poor adherence to high blood pressure treatment, according to Miyong Kim, Ph.D., R.N., lead author and associate professor at the School of Nursing. She adds that the results demonstrate a need for interventions that address depression as an essential component of care for hypertensive patients.

"People who are depressed are more likely to use alcohol or drugs and less likely to take their medication or follow a low-salt diet. This greatly impacts hypertension and can lead to complications and even death," says Kim. "Better screening for depression among hypertensive patients will lead to better treatment of both conditions as well as an improved quality of life for the patient."

The men in the study were between the ages of 30 and 56 and already enrolled in a Johns Hopkins clinical trial of a blood pressure control program. The study revealed a rate of depression among the men that was three times that of the general population. Low income was found to be the most significant factor predicting depression; more than two-thirds of the participants reported an annual income of less than $10,000.

"Many of the urban black men in this study face a harsh environment and challenges in accessing health care, and it's important to acknowledge th
'"/>

Contact: Ming Tai
mtai@jhmi.edu
410-614-5317
Johns Hopkins Medical Institutions
15-Jul-2003


Page: 1 2

Related biology news :

1. Depression traced to overactive brain circuit
2. 16th Annual Depression Symposium features Pulitzer Prize-winning author, world-renowned neurosurgeon
3. Depression worsens outcome in diabetes
4. Depression in later life may be caused by hardened arteries
5. Women With Low Cholesterol May Be At Risk For Depression And Anxiety
6. Inherited Depression Linked To Shortage Of Cells In Brain Region
7. Depression A Risk Factor For Coronary Artery Disease In Men
8. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
9. Whites, African-Americans better rate medical care experiences when seeing same-race physicians
10. Team approach works better to reduce blood pressure in African-American men
11. Does a new hypothesis help explain higher levels of hypertension among African-Americans?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/4/2019)... ... January 03, 2019 , ... Over the ... into their drug discovery research workflows with biology ranging from single cell-type spheroids ... of in vitro studies, they create several challenges that need to be overcome ...
(Date:12/27/2018)... FRANCISCO (PRWEB) , ... December 27, 2018 , ... ... annual Microbiome Conference at JPM as part of the JP Morgan 37th Annual ... innovative scientists and physicians, and members of the investment community. , Since ...
(Date:12/20/2018)... ... December 20, 2018 , ... Human Factors and product ... a new usability/observation room. This addition will help meet the increased industry demand ... delivery devices/combination products are safe and easy to use when released to the ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... Fla. (PRWEB) , ... January ... ... Geometrical Implant Co, (SAGICO), an innovative spinal implant company, announced today that ... in San Francisco, California. The annual J.P. Morgan Healthcare Conference is ...
(Date:1/7/2019)... SEONGNAM, South Korea (PRWEB) , ... January 07, ... ... has completed Phase 1 clinical trials of its Parkinson's Disease drug candidate, code-named ... disease-modifying treatment of Parkinson's Disease. The trial took place in South Korea. ...
(Date:1/4/2019)... ... January 03, 2019 , ... Calidi Biotherapeutics, Inc., ... today announced the founding of a scientific and medical advisory board (SMAB). The ... leaders in the Immuno-Oncology field. The founding members of Calidi Biotherapeutics SMAB include ...
(Date:12/18/2018)... ... December 17, 2018 , ... ABCT ... emerging biosciences ventures invited to participate in the annual program. Twelve ventures will ... plans and a professional network. All startups receive an entrepreneur coach, access to ...
Breaking Biology Technology:
Cached News: